News

Fintel reports that on July 21, 2025, Truist Securities initiated coverage of Neurocrine Biosciences (NasdaqGS:NBIX) with a ...
Medically reviewed by Nicholas R. Metrus, MD Tardive dyskinesia and dystonia are both neurological disorders that can affect ...
Since the tardive dyskinesia is moderately severe, the overall rating always goes with the highest rating on an individual item, and he has two threes, two moderates.